Focusing on the prospective cohort of 52 SARS-CoV-2-positive patients, we found that IP-10 levels were significantly higher in patients classified as severe according to the NIH COVID-19 severity score (n = 26; https://www.covid19treatmentguidelines.nih.gov/. Here, CXCL10 is linked to COVID-19.